Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.560 $0.80 Thursday, 9th May 2024 DBVT stock ended at $0.571. This is 17.77% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 30.36% from a day low at $0.560 to a day high of $0.730.
90 days $0.560 $0.94
52 weeks $0.560 $2.37

Historical DBV Technologies S.A. prices

Date Open High Low Close Volume
Sep 15, 2016 $35.50 $35.76 $35.19 $35.74 32 500
Sep 14, 2016 $34.76 $35.41 $34.76 $35.16 26 200
Sep 13, 2016 $35.12 $35.29 $34.49 $34.72 53 700
Sep 12, 2016 $34.45 $35.29 $34.30 $35.24 70 300
Sep 09, 2016 $35.78 $35.92 $34.79 $34.82 105 500
Sep 08, 2016 $35.56 $36.44 $35.50 $36.30 89 100
Sep 07, 2016 $35.51 $36.05 $35.40 $36.00 88 700
Sep 06, 2016 $35.02 $35.84 $34.95 $35.83 107 300
Sep 02, 2016 $34.63 $34.67 $34.34 $34.47 34 200
Sep 01, 2016 $34.66 $34.96 $34.38 $34.68 60 600
Aug 31, 2016 $35.27 $35.28 $34.29 $34.58 241 100
Aug 30, 2016 $34.99 $35.58 $34.99 $35.30 152 600
Aug 29, 2016 $34.55 $35.20 $34.45 $34.95 60 800
Aug 26, 2016 $34.33 $34.91 $34.25 $34.53 83 900
Aug 25, 2016 $34.24 $34.92 $34.09 $34.47 160 000
Aug 24, 2016 $34.68 $35.51 $34.64 $34.81 152 900
Aug 23, 2016 $34.49 $35.45 $34.45 $34.96 170 800
Aug 22, 2016 $33.39 $34.74 $33.37 $34.56 75 300
Aug 19, 2016 $34.23 $35.00 $34.07 $34.80 86 500
Aug 18, 2016 $33.55 $34.80 $33.42 $34.70 84 300
Aug 17, 2016 $33.37 $34.14 $33.19 $33.97 94 100
Aug 16, 2016 $34.10 $35.35 $34.04 $34.29 97 700
Aug 15, 2016 $33.92 $34.10 $33.73 $33.83 192 400
Aug 12, 2016 $33.31 $33.88 $33.17 $33.52 87 000
Aug 11, 2016 $33.01 $33.92 $32.83 $33.76 65 600
Click to get the best stock tips daily for free!

About DBV Technologies S.A.

DBV Technologies S.A. DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t... DBVT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT